about us
CEO Message
Leadership
Company Overview
History
Investors
technology
PHENOTYPIC SCREENING
TARGET ID/MOA
PROTEOMICS/BIOMARKER
pDOS
SEOUL-FLUOR
FITGE/TS-FITGE
Molecular Splitter for TPU
R&D
Research Interest
Disease Area
Pipeline
order
Bioprobe
media
Press
News
Gallery
Reference
contact us
Location
Tel. +82-2-887-9090
media
spark biopharma
美FDA, 스파크바이오파마 'SBP-401' 희귀의약품 지정
작성자 :
관리자
등록일 : 2024.02.23
조회수
575
기사 원문 :
https://www.press9.kr/news/articleView.html?idxno=58197
목록
